Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |